Todd Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Todd Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$412K	Buy	6,606 +256	+4%	+$16.2K	0.01%	160
2026 Q2	$366K	Hold	6,350	–	–	0.01%	171
2026 Q1	$385K	Buy	6,350 +63	+1%	+$3.67K	0.01%	169
2025 Q4	$339K	Buy	6,287 +462	+8%	+$22.2K	0.01%	168
2025 Q3	$263K	Hold	5,825	–	–	0.01%	170
2025 Q2	$270K	Hold	5,825	–	–	0.01%	166
2025 Q1	$355K	Buy	5,825 +66	+1%	+$3.85K	0.01%	159
2024 Q4	$326K	Buy	+5,759	New	+$322K	0.01%	158
2024 Q2	–	Sell	-278,407	Closed	-$15.1M	–	211
2024 Q1	$15.1M	Sell	278,407 -262,538	-49%	-$13.4M	0.31%	137
2023 Q4	$27.8M	Sell	540,945 -18,325	-3%	-$962K	0.61%	72
2023 Q3	$32.5M	Buy	559,270 +6,193	+1%	+$379K	0.77%	43
2023 Q2	$35.4M	Sell	553,077 -2,006	-0.4%	-$135K	0.82%	39
2023 Q1	$38.5M	Sell	555,083 -13,534	-2%	-$955K	0.93%	30
2022 Q4	$40.9M	Sell	568,617 -1,505	-0.3%	-$113K	0.99%	23
2022 Q3	$40.5M	Buy	570,122 +42,676	+8%	+$3.1M	1.13%	17
2022 Q2	$40.6M	Buy	527,446 +35,113	+7%	+$2.67M	1.05%	15
2022 Q1	$36M	Buy	492,333 +141,606	+40%	+$9.5M	0.79%	42
2021 Q4	$21.9M	Sell	350,727 -17,568	-5%	-$1.03M	0.47%	100
2021 Q3	$21.8M	Sell	368,295 -2,280	-0.6%	-$150K	0.5%	89
2021 Q2	$24.8M	Buy	370,575 +969	+0.3%	+$63.2K	0.56%	80
2021 Q1	$23.3M	Sell	369,606 -168,037	-31%	-$10.5M	0.55%	83
2020 Q4	$33.4M	Sell	537,643 -2,545	-0.5%	-$156K	0.85%	38
2020 Q3	$32.6M	Buy	540,188 +26,785	+5%	+$1.61M	0.97%	27
2020 Q2	$30.2M	Buy	+513,403	New	+$30.7M	0.96%	25
2014 Q2	–	Sell	-5,306	Closed	-$276K	–	216
2014 Q1	$276K	Hold	5,306	–	–	0.01%	192
2013 Q4	$282K	Sell	5,306 -280	-5%	-$14.3K	0.01%	194
2013 Q3	$259K	Sell	5,586 -25,396	-82%	-$1.11M	0.01%	196
2013 Q2	$1.38M	Buy	+30,982	New	+$1.35M	0.05%	189

Other funds holding BMY

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Todd Asset Management's BMY Position: Q3 2026 in Review

Todd Asset Management increased its Bristol-Myers Squibb (BMY) stake by 4% in Q3 2026, buying an estimated $16.2K and bringing the position to 6,606 shares worth $412K. The position accounts for 0.01% of the portfolio, ranked #160.

Todd Asset Management first reported a position in BMY in Q2 2013 and has held it in 28 quarters since. The position peaked at $40.9M in Q4 2022. 1,127 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Todd Asset Management held 6,606 shares of Bristol-Myers Squibb worth $412K as of Q3 2026.
Todd Asset Management bought 256 Bristol-Myers Squibb shares in Q3 2026, an estimated $16.2K.
Bristol-Myers Squibb made up 0.01% of Todd Asset Management's portfolio in Q3 2026, its #160 holding.
Todd Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 28 quarters since.
Todd Asset Management's Bristol-Myers Squibb position peaked at $40.9M in Q4 2022.
1,127 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Todd Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.